H1 is a start-up company that gathers information from healthcare professionals. It recently completed a $100 million financing led by Altimeter Capital. The startup plans to use the funds to build its network of clinicians and researchers, as well as to develop new features and hire more employees.
H1, headquartered in New York, has some similarities with social networking sites Toxic In this health system, pharmaceutical companies and medical device companies use it to find information about clinicians. However, H1 focuses more on the research side of healthcare.
Ariel Katz, co-founder and CEO of H1, stated in a press release: “No other company can match the quantity and quality of global healthcare data that H1 has, so no one can match the insights we present. Comparable.” “Our next phase of growth will focus on helping medical institutions use our network to make better decisions.”
The company has filled approximately 10 million pieces of information about clinicians and researchers. For example, it builds a tool for the health system to identify suppliers and a positioning function for medical device sales.
Recently, it Built a function For pharmaceutical companies to obtain information about doctors or clinical trial locations. For example, a company can aggregate information about the language spoken by its physician investigators, or whether a clinical trial site requires equipment. Katz said H1 had this idea after a pharmaceutical company asked their doctors about the diversity in a major clinical trial.
Although H1 has so far focused more on the functions of healthcare and pharmaceutical companies, it has also begun to add features to individual clinicians, allowing them to add to their profiles and looking for opportunities to collaborate with peers or clinical trials.
Some of its clients include Columbia University, the University of Pennsylvania, and 7 of the top 10 pharmaceutical companies.
Photo: Topp_Yimgrimm, Getty Images
